Announcements Trials
Browse Landscape

Phase

Phase 2 28Phase 3 7Phase 2/3 6Phase 1/2 4Phase EARLY_PHASE1 3Phase NA 1Phase 4 1

Status

Recruiting 3Withdrawn 1Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 4INDUSTRY 2NETWORK 1

Study Type

Interventional 7

Sponsor

Cancer Type

Breast 105Gynecologic 7Other 1Endocrine 1

Conditions

Fallopian Tube Neoplasms 2Carcinoma, Ovarian Epithelial 2Peritoneal Neoplasms 1Ovarian Neoplasms 1Low Grade Serous Ovarian Cancer 1Hereditary Breast and Ovarian Cancer Syndrome 1Endometrial Neoplasms 1Breast Neoplasms 1

Interventions

Paclitaxel 150Carboplatin 110Cisplatin 94Bevacizumab 42Topotecan 39Gemcitabine 38liposomal doxorubicin 34Radiotherapy 29Doxorubicin 27Brachytherapy 26Taxes 24pembrolizumab 20olaparib 20Drug Therapy 20Hyperthermic Intraperitoneal Chemotherapy 16Chemotherapy, Adjuvant 16human papillomavirus vaccine, L1 type 16, 18 15Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 14Docetaxel 13Neoadjuvant Therapy 12Platinum 10niraparib 9Radiation 91,2-diaminocyclohexaneplatinum II citrate 9Vaccines, Synthetic 8Surgical Procedures, Operative 8atezolizumab 7Specimen Handling 7Papillomavirus Vaccines 7Letrozole 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

7 trials
RecentStart dateEnrollment
Phase 3 × Letrozole × Gynecologic × Clear all
NCT06072781 2026-04-02

RAMP 301

Verastem, Inc.

Phase 3 Recruiting
270 enrolled
Gynecologic

Low Grade Serous Ovarian Cancer

NCT04095364 2026-03-24

Letrozole With or Without Paclitaxel and Carboplatin in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NRG Oncology

Phase 3 Active not recruiting
450 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT04111978 2025-09-29

MATAO

Swiss GO Trial Group

Phase 3 Recruiting
540 enrolled
Gynecologic

Fallopian Tube Neoplasms, Peritoneal Neoplasms

NCT04421547 2025-03-07

MITO32

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Phase 3 Terminated
86 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT05601700 2025-01-27

LEPRE

Ente Ospedaliero Ospedali Galliera

Phase 3 Recruiting
132 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial

NCT00673335 2024-07-01

LIBER

UNICANCER

Phase 3 Completed
170 enrolled
BreastGynecologic

Breast Neoplasms, Hereditary Breast and Ovarian Cancer Syndrome

NCT05712941 2023-11-03

Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer

EQRx International, Inc.

Phase 3 Withdrawn
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡